0W1Q Stock Chart & Stats
€22.20
€2.00(8.93%)
At close: 4:00 PM EST
€22.20
€2.00(8.93%)
Day’s Range― - ―
52-Week Range€15.50 - €29.70
Previous CloseN/A
Volume61.00
Average Volume (3M)79.00
Market Cap
€119.02M
Enterprise Value€141.07M
Total Cash (Recent Filing)€2.82M
Total Debt (Recent Filing)€15.37M
Price to Earnings (P/E)1.1
Beta0.99
Next Earnings
Nov 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield17.86%
Share Statistics
EPS (TTM)25.01
Shares Outstanding4,281,384
10 Day Avg. Volume171
30 Day Avg. Volume79
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)0.39
Price to Sales (P/S)0.26
P/FCF Ratio765.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)8.7
Revenue Forecast (FY)€41.20M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage gives MPH Health Care substantial financial flexibility and reduces the burden of interest and refinancing obligations. This supports resilience during periods of weaker portfolio performance and preserves capacity to manage or develop healthcare investments over the next several quarters.
Return To ProfitabilityA return to sustained positive earnings since 2022 indicates that the holding company has regained profitability after earlier losses. The solid 2025 net margin provides an operating base for continued portfolio management, although the quality of earnings remains linked to investment performance.
Healthcare Investment ExposureMPH Health Care has a defined structural focus on pharmaceuticals and healthcare services rather than a single product line. Exposure to multiple healthcare-related holdings can provide access to several areas of sector growth while allowing the company to allocate capital across its investment portfolio.
Bears Say
Highly Erratic RevenueHighly unstable revenue makes it difficult to assess the durability of MPH Health Care’s top-line performance and forecast future earnings. Large swings may also complicate capital allocation and reduce confidence that recent profitability represents a steadily expanding earnings base.
Volatile Cash GenerationInconsistent operating cash flow and renewed weakness in 2025 show that reported earnings do not reliably convert into cash. This limits self-funding capacity, makes distributions or new investments more dependent on portfolio events, and reduces confidence in the persistence of financial results.
Dependence On Portfolio PerformanceAs a holding company, MPH Health Care depends substantially on the operating performance and valuation of its underlying investments. Earnings can therefore fluctuate with portfolio-company distributions, realized transactions, and market conditions rather than following a consistent operating revenue model.
0W1Q FAQ
What was MPH Health Care AG’s price range in the past 12 months?
MPH Health Care AG lowest share price was €15.50 and its highest was €29.70 in the past 12 months.
What is MPH Health Care AG’s market cap?
MPH Health Care AG’s market cap is €119.02M.
When is MPH Health Care AG’s upcoming earnings report date?
MPH Health Care AG’s upcoming earnings report date is Nov 25, 2026 which is in 27 days.
How were MPH Health Care AG’s earnings last quarter?
MPH Health Care AG released its earnings results on Sep 16, 2026. The company reported €1.169 earnings per share for the quarter.
Is MPH Health Care AG overvalued?
According to Wall Street analysts MPH Health Care AG’s price is currently Overvalued.
Does MPH Health Care AG pay dividends?
MPH Health Care AG pays a Annually dividend of €5 which represents an annual dividend yield of 17.86%. See more information on MPH Health Care AG dividends here
What is MPH Health Care AG’s EPS estimate?
MPH Health Care AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MPH Health Care AG have?
MPH Health Care AG has 4,281,384 shares outstanding.
What happened to MPH Health Care AG’s price movement after its last earnings report?
MPH Health Care AG reported an EPS of €1.169 in its last earnings report. Following the earnings report the stock price went down -2.867%.
Which hedge fund is a major shareholder of MPH Health Care AG?
Currently, no hedge funds are holding shares in GB:0W1Q
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
MPH Health Care AG Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
87.92%
12-Months-Change
Fundamentals
Return on Equity
43.53%
Trailing 12-Months
Asset Growth
21.86%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
MPH Health Care AG
MPH Health Care AG is a German-based investment firm with a primary focus on the healthcare sector. The company's portfolio includes the production and distribution of medicinal products designed to treat serious illnesses like cancer, HIV, and various other chronic conditions. Beyond pharmaceuticals, it also delivers medical aesthetic treatments, develops and markets a diverse array of pharmaceutical and medical items, and furnishes related services and specialized medical devices for use in aesthetic surgery and cosmetic dermatology. Furthermore, its operations extend to supplying cytostatic solutions and involvement in real estate ventures. Established in Berlin in 2008, the company adopted its current name, MPH Health Care AG, in 2017, having previously been known as MPH Mittelständische Pharma Holding AG. It functions as a subsidiary of Magnum AG.